Direkt zum Inhalt
Merck
  • Identification of the novel dfrK-carrying transposon Tn559 in a porcine methicillin-susceptible Staphylococcus aureus ST398 strain.

Identification of the novel dfrK-carrying transposon Tn559 in a porcine methicillin-susceptible Staphylococcus aureus ST398 strain.

Antimicrobial agents and chemotherapy (2010-05-26)
Kristina Kadlec, Stefan Schwarz
ZUSAMMENFASSUNG

The trimethoprim resistance gene dfrK was found to be part of the novel Tn554-related transposon Tn559 integrated in the chromosomal radC gene of a porcine methicillin-susceptible Staphylococcus aureus ST398 strain. While Tn559 and Tn554 had similar arrangements of the transposase genes tnpA, tnpB, and tnpC, the Tn554-associated resistance genes erm(A) and spc were replaced by dfrK in Tn559. Circular forms of Tn559 were detected and suggest the functional activity of this transposon.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Ampicillin, anhydrous, 96.0-102.0% (anhydrous basis)
Sigma-Aldrich
Erythromycin, BioReagent, suitable for cell culture
Sigma-Aldrich
Trimethoprim, ≥98.5%
Sigma-Aldrich
Tetracyclin, 98.0-102.0% (HPLC)
Sigma-Aldrich
Trimethoprim, ≥99.0% (HPLC)
Sigma-Aldrich
Enrofloxacin, ≥99.0%
Sigma-Aldrich
Erythromycin, potency: ≥850 μg per mg
Supelco
Enrofloxacin, VETRANAL®, analytical standard
Supelco
Trimethoprim, VETRANAL®, analytical standard
Sigma-Aldrich
Erythromycin, meets USP testing specifications
Sigma-Aldrich
Erythromycin, tested according to Ph. Eur.